Importance of hematocrit for a tacrolimus target concentration strategy
作者： Elisabet Størset , Nick Holford , Karsten Midtvedt , Sara Bremer , Stein Bergan
DOI: 10.1007/S00228-013-1584-7
关键词: Kidney transplantation 、 Medicine 、 Urology 、 Pharmacology 、 Hematocrit 、 Biological availability 、 Tacrolimus 、 Kidney transplant 、 Individual dose 、 Target concentration 、 Patient characteristics
摘要: Purpose To identify patient characteristics that influence tacrolimus individual dose requirement in kidney transplant recipients.
springer.com
core.ac.uk
paperity.org
researchgate.net 参考文章(43)
Thomas Kerbusch, Ulrika Wählby, Peter A. Milligan, Mats O. Karlsson, Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first-pass metabolism, CYP2D6 genotype and formulation-dependent bioavailability. British Journal of Clinical Pharmacology. ,vol. 56, pp. 639- 652 ,(2003) , 10.1046/J.1365-2125.2003.01967.X
Katherine A. Barraclough, Nicole M. Isbel, Carl M. Kirkpatrick, Katie J. Lee, Paul J. Taylor, David W. Johnson, Scott B. Campbell, Diana R. Leary, Christine E. Staatz, Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients British Journal of Clinical Pharmacology. ,vol. 71, pp. 207- 223 ,(2011) , 10.1111/J.1365-2125.2010.03815.X
Jean-Baptiste Woillard, Brenda C. M. de Winter, Nassim Kamar, Pierre Marquet, Lionel Rostaing, Annick Rousseau, Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily Advagraf British Journal of Clinical Pharmacology. ,vol. 71, pp. 391- 402 ,(2011) , 10.1111/J.1365-2125.2010.03837.X
Dirk R J Kuypers, Kathleen Claes, Pieter Evenepoel, Bart Maes, Willy Coosemans, Jacques Pirenne, Yves Vanrenterghem, Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients. Clinical Pharmacokinectics. ,vol. 43, pp. 741- 762 ,(2004) , 10.2165/00003088-200443110-00005
P. A. Jacobson, D. Schladt, W. S. Oetting, R. Leduc, W. Guan, A. J. Matas, A. Israni, Lower Calcineurin Inhibitor Doses in Older Compared to Younger Kidney Transplant Recipients Yield Similar Troughs American Journal of Transplantation. ,vol. 12, pp. 3326- 3336 ,(2012) , 10.1111/J.1600-6143.2012.04232.X
Elisabet Størset, Christine Staatz, Stefanie Hennig, Nick Holford, Troels K. Bergmann, Identification of continuous covariate relationships 15th Annual Population Approach Group Australia and New Zealand Meeting (PAGANZ 2013). ,(2013)
Jolanta Malyszko, Rainer Oberbauer, Bruno Watschinger, Anemia and erythrocytosis in patients after kidney transplantation. Transplant International. ,vol. 25, pp. 1013- 1023 ,(2012) , 10.1111/J.1432-2277.2012.01513.X
R. Bouamar, N. Shuker, D. A. Hesselink, W. Weimar, H. Ekberg, B. Kaplan, C. Bernasconi, T. van Gelder, Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†). American Journal of Transplantation. ,vol. 13, pp. 1253- 1261 ,(2013) , 10.1111/AJT.12191
H. Zahir, G. McCaughan, M. Gleeson, R. A. Nand, A. J. McLachlan, Factors affecting variability in distribution of tacrolimus in liver transplant recipients. British Journal of Clinical Pharmacology. ,vol. 57, pp. 298- 309 ,(2003) , 10.1046/J.1365-2125.2003.02008.X
Takashi Tomita, Masato Homma, Yuichi Hasegawa, Hiroshi Kojima, Nobuhiro Ohkohchi, Tetsuo Hori, Michio Kaneko, Yasuko Nakano, Takashi Tobe, Yukinao Kohda, Use of sample hematocrit value to correct blood tacrolimus concentration derived by microparticle enzyme immunoassay. Biological & Pharmaceutical Bulletin. ,vol. 31, pp. 1250- 1253 ,(2008) , 10.1248/BPB.31.1250